Table 1.
Lymphoma patient characteristics in two groups
| MPV3 (n = 23) | MTX5 (n = 15) | |
|---|---|---|
| Age, years (median) | 17–75 (61) | 43–71 (63) |
| Sex | ||
| Male | 17 (74%) | 11 (73%) |
| Female | 6 (26 %) | 4 (27%) |
| KPS on admission (median) | 40–90 (60) | 30–90 (60) |
| Diagnosis | ||
| Surgery | ||
| Removal | 0 (0%) | 1 (7%) |
| Biopsy | 21 (91 %) | 9 (60 %) |
| Cytology | 0 (0%) | 3 (20%) |
| Others | 2 (9%) | 2 (13%) |
| Pathology | ||
| B-cell lymphoma | 19 (83%) | 13 (87%) |
| DLBCL | 19 (83%) | 10 (67%) |
| Others | 4 (17%) | 2 (13%) |
DLBCL: diffuse large B-cell lymphoma, KPS: Karnofsky performance status, MPV: methotrexate + procarbazine + vincristine, MTX: methotrexate, N: number.